Glenmark Pharmaceuticals announces first in the world launch of its novel, globally-researched, latest-in-class diabetes medicine “Remogliflozin” in India
Pune, India; May 07, 2019: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of its novel, patent protected and...
